Dalvir Gill PhD

Chief Executive Officer, TransCelerate BioPharma, Inc.

Dr. Dalvir Gill has >25 years of drug development experience. Prior to his appointment as CEO of TransCelerate Biopharma, he was the President of a Phase II-IV Drug Development at Inventive Health Clinical, an international CRO.


This speaker has made no appearances.